Chrysalix Venture Capital, a Vancouver, BC, Canada- and Delft, The Netherlands-based venture capital firm, announced the first close of its new $120m fund.
Optina Diagnostics Inc., a Montreal, Canada-based provider of an early detection of Alzheimer through the use of Artificial Intelligence (AI) and Spectral Retinal Imaging, raised C$4m in funding.
Moz, Inc., a Seattle, WA-based provider of search engine optimization technology solutions, acquired Stat Search Analytics, a Vancouver, Canada-based leader in rank tracking and SERP (search engine result page) analytics for enterprises and digital agencies.
Tangerine has announced their partnership with the new digital banking solutions, Meniga.
VueReal Inc., a Waterloo, Canada-based developer of key technologies for micro- and nano-devices, raised $8.5m in funding.
CrowdRiff, a Toronto, Canada-based AI-powered visual content marketing platform for travel brands, raised a $9m Series A funding round.
Kooltra, a Toronto, Canada-based cloud platform for financial institutions and non-bank firms to modernize and automate foreign exchange (FX) operations, closed CAD $6.5m in funding.
Hopper, a Montreal, Canada- and Cambridge, MA-based travel booking app, raised $100m (CA ~$128m) in Series D financing.
Thentia, a Toronto, Canada-based regulatory and compliance software provider, entered into a venture debt funding partnership with Espresso Capital.
Daisy Intelligence Corporation, a Toronto, CA-based artificial intelligence software-as-a-service platform, received $5m in funding.
Pai Health, the Vancouver, Canada-based developer of the Personal Activity Intelligence score, raised $9m in funding.
AbCellera, a Vancouver, BC, Canada-based developer of next-generation therapeutic antibodies, closed its $10m Series A financing.
Twenty Billion Neurons GmbH, a Berlin, Germany- and Toronto, Canada-based provider of real-time, interactive computer vision and artificial intelligence (AI) solutions, raised $10m in Series A funding.
GHGSat, a Montreal, Canada-based company providing global emissions monitoring services, raised US$10M Series A2 financing.
Phoenix Molecular Designs, a Vancouver, British Columbia, Canada-based biotechnology company designing precise cancer therapeutics by targeting essential kinases, completed a $2.7M financing.